Related Experiment Video
Updated: Jun 2, 2026
07:09
Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms
Published on: December 1, 2014
Policy implications of oral agents
Sandra L Spoelstra1, Barbara A Given, Charles W Given
1College of Nursing, Michigan State University, East Lansing, MI 48824, USA.
Seminars in Oncology Nursing
|April 26, 2011
Summary
Patients need education on safely handling oral antineoplastic agents. Cancer centers should update protocols for effective cancer treatment and improved patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Patient Education
Background:
- Oral antineoplastic agents are increasingly used in cancer care.
- Safe handling, storage, and administration are crucial for treatment efficacy.
- Patients and families require comprehensive understanding of medication management.
Purpose of the Study:
- To highlight the importance of patient and family education for oral antineoplastic agents.
- To emphasize the need for standardized protocols in cancer centers.
- To underscore the role of clinicians in monitoring and facilitating oral chemotherapy administration.
Main Methods:
- Review of research-based articles.
- Analysis of conference presentations.
Main Results:
- Effective cancer treatment requires patient and family understanding of medication administration.
- Clear protocols are necessary for safe handling and storage.
- Clinician monitoring is essential for optimal outcomes.
Conclusions:
- Cancer centers must adapt policies and protocols for safe oral antineoplastic agent administration.
- Clinicians play a vital role in facilitating administration and improving patient outcomes.
- Enhanced patient education is key to successful oral chemotherapy management.
More Related Videos
Related Concept Videos
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:24Factors Influencing Drug Absorption: Presystemic Elimination
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
01:18Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...